For metabolic modulation, GOx@FeNPs, which combine glucose oxidase (GOD)-enhanced ferroptosis with photothermal ICD and anti-PD-L1 blockade, have demonstrated impressive tumor suppression in colorectal cancer models. Here, CD274 is linked to neoplasm.